TAG:
dso
Business Buzz Saw Hits Anatomic Path Firms
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: In recent years, both companies have enjoyed sustained and rapid growth in offering anatomic pathology (AP) services nationally. The departure of CFOs from both companies, each for different reasons, is a sign that such unbridled growth has created unique problems for each AP…
Commercial Lab JVs With Hospitals Are Declining In Number
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: There are many reasons why a properly-designed and well-managed laboratory test joint venture (JV) between a commercial lab company and a hospital should succeed. But no matter how strong such concepts look on paper, the real world has proven to be a harsh environment. A hand…
Sigma-Aldrich, Ivax Diagnostics, i-STAT, Quest Diagnostics, Unilab
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
SIGMA-ALDRICH SELLS ITS EIA PRODUCT LINE TO IVAX DIAGNOSTICS FOLLOWING ITS DECISION TO EXIT the clinical diagnostics market, Sigma-Aldrich, Inc. has sold its global enzyme immunoassay (EIA) product line to Ivax Diagnostics, Inc., based in Miami, Florida. Th…
Quest Pays $1.1 Billion To Acquire Unilab Corp.
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
CEO SUMMARY: Quest Diagnostics Incorporated is showing its muscle. The dust had hardly settled on its $500 million acquisition of American Medical Laboratories when the lab industry’s behemoth announced that it would pay $1.1 billion to buy Unilab, by far the largest lab testing company…
Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
ACTIVITY AT DYNACARE HINTS AT POSSIBLE SALE, LABCORP MAY BE BUYER With Quest Diagnostics Incorporated snapping up independent lab companies right and left in recent months, the question asked by many is “Where’s Laboratory Corporation of America?” On …
More Consolidation: Quest Acquires AML
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
CEO SUMMARY: In December, American Medical Laboratories, Inc. (AML) was preparing a second attempt to raise capital through an initial public offering (IPO). But a tempting purchase offer by Quest Diagnostics Incorporated led to a decision by AML’s owners to sell the company. This trans…
Sunquest, Towers Perrin, Aetna, Quest Diagnostics, Roche Diagnostics, Careside
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
SUNQUEST REAFFIRMS LONG-TERM COMMITMENT TO COPATHPLUS PRODUCT EXPECT A FASCINATING competitive battle in the market for anatomic pathology software now that Cerner Corporation is acquiring Dynamic Healthcare Technologies, Inc. (DHT) DHT is the developer an…
Terrorist Attacks Affect Many of Nation’s Labs
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
CEO SUMMARY: Following terrorist attacks in New York City and Washington, DC, the total shutdown of commercial air traffic in the United States for 48 hours disrupted the regular shipment of reference and esoteric lab specimens to national laboratories. Swiftly-implemented contingency eff…
Deluge of Blood Donors Triggers Response by OCD
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
CEO SUMMARY: It’s the story behind the story. Even as overwhelming numbers of people nationwide rushed to donate blood following September 11’s terrorist attacks, blood bankers in many cities found themselves rapidly depleting their existing inventories of supplies and test kits. One …
Events Trigger Several Responses from Quest
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
CEO SUMMARY: Terrorist attacks on September 11 impacted Quest Diagnostics Incorporated in a number of unexpected ways. Security measures in New York City and Washington, DC impeded normal courier activities. The immediate shutdown of all air traffic nationwide meant that air-freighted spe…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized